What You Need To Know HIV testing, STD screening and community education programs are all at risk of ending in LA County when federal funds expire at the end of May The county receives $19.45 million ...

Anal cancer screening among men who have sex with men with HIV aged 35 years and older appeared cost-effective and could decrease anal cancer incidence and mortality, according to research published ...

Increased PrEP usage is linked to decreased HIV diagnosis rates, with a notable decline from 13.0 to 10.6 per 100,000 over a decade. State-level PrEP coverage significantly impacts HIV diagnosis rates ...

The CDC, too, has stepped up its outreach to African American women, said Franciso Ruiz, team leader for national partnerships in the division of HIV/AIDS prevention. Its Pact to Act Against AIDS ...

Among heterosexuals, poverty — not race — was associated with higher prevalence. In 2008, the CDC first published HIV incidence estimates that were based on directly measured recent infection ...

African American MSM exhibit the highest prevalence (CDC, 2005b) and incidence (CDC, 2001) of HIV infection, with Latino MSM exhibiting the next highest rates.

The disproportionate rates of HIV prevalence (CDC, 2005 a,b) and incidence (CDC, 2001) in African American MSM compared to other MSM is puzzling in light of their lower rate of MSM risk behavior.

It also reflects a deeper problem in medicine and public health: the assumption that queer sex is inherently dangerous. This ...

Objective: The practice of using drugs to modulate experiences is a well-documented phenomenon worldwide, particularly among men who have sex with men (MSM). This study aims to describe patterns of ...

Dozens of HIV experts at the Centers for Disease Control and Prevention received emails earlier this month revoking notices they received 10 weeks ago that laid them off. Damage to ...

The Food and Drug Administration has approved a breakthrough medication that reduces the risk of contracting HIV by 96 percent. Sign up for the Out Newsletter to keep up with what's new in LGBTQ+ ...

The twice-yearly injectable drug’s potential could be compromised by the Trump administration’s dramatic cuts to HIV-prevention infrastructure in the U.S.